VIKING GLOBAL INVESTORS LP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$256,858,415
-15.2%
9,464,201
-3.9%
1.04%
-16.0%
Q2 2023$302,817,650
-25.0%
9,850,932
-12.1%
1.24%
-34.6%
Q1 2023$403,689,091
+2.1%
11,204,249
+11.9%
1.90%
-4.3%
Q4 2022$395,536,355
-9.5%
10,008,511
-8.0%
1.98%
-1.9%
Q3 2022$437,222,000
-15.9%
10,881,594
-12.0%
2.02%
-15.1%
Q2 2022$520,064,000
+24.0%
12,370,694
+14.9%
2.38%
+40.3%
Q1 2022$419,384,000
+2.0%
10,764,472
+4.4%
1.70%
+43.2%
Q4 2021$411,068,000
+174.7%
10,315,378
+149.1%
1.18%
+188.8%
Q3 2021$149,638,000
+12.7%
4,140,508
+27.8%
0.41%
+2.0%
Q2 2021$132,752,000
+47.6%
3,238,654
+57.1%
0.40%
+50.0%
Q1 2021$89,934,000
-21.4%
2,061,753
-9.8%
0.27%
-14.9%
Q4 2020$114,464,000
+39.7%
2,287,000
+17.4%
0.32%
+6.4%
Q3 2020$81,955,000
-32.9%
1,948,064
-22.5%
0.30%
-43.9%
Q2 2020$122,103,0002,514,9850.53%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders